STRYKER CORP (SYK)
Surgical & Medical Instruments & Apparatus · Healthcare · $116.2B
Intrinsic Value (Consensus)
$154.97
Current Price
$310.58
Margin of Safety
-50.1%
50.1% Above Intrinsic Value
Value: $155
Price: $311
Valuation Model Estimates
Current Price: $310.58
DCF (Discounted Cash Flow)
$537.03
Graham Number
$76.99
Earnings Power Value
$81.55
Relative Value (P/E)
$168.00
Dividend Discount Model
$293.33
Consensus Value
$154.97
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
78
Profitability
25/25
Strength
24/25
Valuation
7/25
Growth
22/25
Financial Health Signals
Strong profitability — ROE of 28% (above 20% is excellent)
Low debt — conservative balance sheet
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $8.40
- EPS (Forward)
- $10.08
- Book Value
- $31.36
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 27.7%
- Debt/Equity
- 15%
- Revenue Growth
- 314.7%
- Earnings Growth
- 20.0%
- Dividend Yield
- 0.5%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance